Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pyoderma gangrenosum: a great marauder.

Grace Ma1, Glyn Jones, Gregory MacKay

  • 1Department of Plastic and Reconstructive Surgery, Emory University, Atlanta, GA 30308, USA.

Annals of Plastic Surgery
|May 1, 2002
PubMed
Summary

Pyoderma gangrenosum is a rare, necrotizing skin disease that can mimic infection but is immunologically mediated. Prompt diagnosis and systemic treatment are crucial for managing this ulcerative condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remdesivir and Nitazoxanide for Chronic Norovirus Type 1 Infection in a Child Post-cardiac Transplantation.

The Pediatric infectious disease journal·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Safety and efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the phase 2 STRIDE study.

Journal of the American Academy of Dermatology·2025
Same author

Clinical evaluation of adults undergoing elective surgery utilizing intraoperative incisional wound irrigation (CLEAN Wound): protocol for a randomised controlled trial.

BMJ open·2025
Same author

Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging phase 2 study.

Journal of the American Academy of Dermatology·2025
Same author

Overcoming barriers to accessing sacral neuromodulation care in Canada Re: "Urologist-perceived barriers and perspectives on the underuse of sacral neuromodulation for overactive bladder in Canada" (Can Urol Assoc J 2023;17:E165-71).

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025

Area of Science:

  • Dermatology
  • Immunology
  • Wound Healing

Background:

  • Pyoderma gangrenosum (PG) is a rare, ulcerative skin disease characterized by progressive necrosis.
  • It often mimics infectious processes but is refractory to antibiotics and local wound care.
  • The exact etiology remains unknown, though immune system dysregulation is suspected.

Observation:

  • A 67-year-old woman developed a necrotic ulcer at a chest tube site.
  • The lesion rapidly spread, covering 15% of her body surface area despite conventional treatment.
  • A septic clinical picture emerged despite sterile cultures, necessitating surgical debridements.

Findings:

  • The patient's condition continued to worsen, leading to a diagnosis of pyoderma gangrenosum.
  • Treatment with systemic steroids and hyperbaric oxygen (HBO) was initiated.

Related Experiment Videos

  • The patient eventually underwent successful skin grafting.
  • Implications:

    • This case highlights the diagnostic challenges of pyoderma gangrenosum, particularly at iatrogenic sites.
    • Early consideration of immune-mediated etiologies is vital for refractory ulcerative lesions.
    • Multimodal treatment, including immunosuppression and advanced wound care, can be effective.